Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Claral
2. Nerisona
3. Nerisone
4. Nerisone Forte
5. Temetex
1. 59198-70-8
2. Diflucortolone 21-valerate
3. Diflucortolone Valerate [jan]
4. Nerisona
5. [2-[(6s,8s,9r,10s,11s,13s,14s,16r,17s)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-7,8,11,12,14,15,16,17-octahydro-6h-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] Pentanoate
6. Nerisone
7. Temetex
8. Texmeten
9. 1a63z067c8
10. Afusona
11. Dsstox_cid_28524
12. Dsstox_rid_82796
13. Dsstox_gsid_48598
14. Difluocortolone Valerianate
15. Difluocortolone Valerate
16. Cas-59198-70-8
17. Diflucortolonevalerate
18. Diflucortolonvalerianat
19. Diflucortolonvalerianat [german]
20. Einecs 261-655-8
21. Brn 2030579
22. Unii-1a63z067c8
23. Ncgc00183100-01
24. Afusona (tn)
25. Diflucortolon Valerate
26. Schembl3015
27. 6-alpha,9-difluoro-11-beta-hydroxy-16-alpha-methyl-21-valeryloxy-1,4-pregnadiene-3,20-dione
28. 6-alpha,9-difluoro-11-beta-hydroxy-21-valeryloxy-16-alpha-methyl-1,4-pregnadiene-3,20-dione
29. 6alpha,9-difluoro-11beta,21-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 21-valerate
30. Chembl2358130
31. Diflucortolone Valerate (jp17)
32. Dtxsid1048598
33. Chebi:31484
34. Zinc4212943
35. Tox21_112929
36. Hy-u00058
37. S5414
38. Diflucortolone Valerate Assay Standard
39. Akos015901782
40. Tox21_112929_1
41. Ccg-269528
42. Diflucortolone Valerate [mart.]
43. Diflucortolone Valerate [who-dd]
44. Diflucortolone Valerate Impurity Standard
45. Diflucortolone 21-valerate [mi]
46. Ncgc00263574-01
47. Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11-hydroxy-16-methyl-21-((1-oxopentyl)oxy)-, (6-alpha,11-beta,16-alpha)-
48. Cs-0021944
49. D01764
50. E86978
51. 198d708
52. Q-200986
53. Q10860261
Molecular Weight | 478.6 g/mol |
---|---|
Molecular Formula | C27H36F2O5 |
XLogP3 | 4.2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 7 |
Exact Mass | 478.25308057 g/mol |
Monoisotopic Mass | 478.25308057 g/mol |
Topological Polar Surface Area | 80.7 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 943 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Inflammatory Agents
Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Diflucortolone Valerate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diflucortolone Valerate, including repackagers and relabelers. The FDA regulates Diflucortolone Valerate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diflucortolone Valerate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Diflucortolone Valerate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Diflucortolone Valerate supplier is an individual or a company that provides Diflucortolone Valerate active pharmaceutical ingredient (API) or Diflucortolone Valerate finished formulations upon request. The Diflucortolone Valerate suppliers may include Diflucortolone Valerate API manufacturers, exporters, distributors and traders.
click here to find a list of Diflucortolone Valerate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Diflucortolone Valerate DMF (Drug Master File) is a document detailing the whole manufacturing process of Diflucortolone Valerate active pharmaceutical ingredient (API) in detail. Different forms of Diflucortolone Valerate DMFs exist exist since differing nations have different regulations, such as Diflucortolone Valerate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Diflucortolone Valerate DMF submitted to regulatory agencies in the US is known as a USDMF. Diflucortolone Valerate USDMF includes data on Diflucortolone Valerate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Diflucortolone Valerate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Diflucortolone Valerate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Diflucortolone Valerate Drug Master File in Japan (Diflucortolone Valerate JDMF) empowers Diflucortolone Valerate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Diflucortolone Valerate JDMF during the approval evaluation for pharmaceutical products. At the time of Diflucortolone Valerate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Diflucortolone Valerate suppliers with JDMF on PharmaCompass.
Diflucortolone Valerate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Diflucortolone Valerate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Diflucortolone Valerate GMP manufacturer or Diflucortolone Valerate GMP API supplier for your needs.
A Diflucortolone Valerate CoA (Certificate of Analysis) is a formal document that attests to Diflucortolone Valerate's compliance with Diflucortolone Valerate specifications and serves as a tool for batch-level quality control.
Diflucortolone Valerate CoA mostly includes findings from lab analyses of a specific batch. For each Diflucortolone Valerate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Diflucortolone Valerate may be tested according to a variety of international standards, such as European Pharmacopoeia (Diflucortolone Valerate EP), Diflucortolone Valerate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diflucortolone Valerate USP).
LOOKING FOR A SUPPLIER?